LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 95 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,558,636 | -73.7% | 1,740,569 | -43.1% | 0.58% | -70.6% |
| Q2 2023 | $9,732,609 | +34.7% | 3,060,569 | 0.0% | 1.98% | +43.7% |
| Q1 2023 | $7,222,943 | -32.0% | 3,060,569 | 0.0% | 1.38% | -34.3% |
| Q4 2022 | $10,620,174 | -52.7% | 3,060,569 | 0.0% | 2.10% | -48.2% |
| Q3 2022 | $22,434,000 | +12.4% | 3,060,569 | 0.0% | 4.04% | +3.6% |
| Q2 2022 | $19,955,000 | +199.4% | 3,060,569 | +131.9% | 3.90% | +200.9% |
| Q1 2022 | $6,666,000 | -34.8% | 1,320,000 | 0.0% | 1.30% | -33.6% |
| Q4 2021 | $10,217,000 | – | 1,320,000 | – | 1.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $69,963,292 | 35.72% |
| Orland Properties Ltd | 15,093,969 | $52,376,072 | 27.91% |
| Foresite Capital Management IV, LLC | 10,000,000 | $34,700,000 | 14.82% |
| MIC Capital Management UK LLP | 3,060,569 | $10,620,174 | 2.10% |
| Alphabet Inc. | 5,865,125 | $20,351,984 | 1.18% |
| HSG Holding Ltd | 3,045,997 | $10,569,610 | 1.07% |
| Artal Group S.A. | 700,000 | $2,429 | 0.14% |
| Eagle Health Investments LP | 100,000 | $347,000 | 0.08% |
| Virtus ETF Advisers LLC | 39,345 | $136,527 | 0.07% |
| BBR PARTNERS, LLC | 164,041 | $569,222 | 0.06% |